These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs. Coschignano MA; De Ciuceis C; Agabiti-Rosei C; Brami V; Rossini C; Chiarini G; Malerba P; Famà F; Cosentini D; Muiesan ML; Salvetti M; Petelca A; Capellini S; Arnoldi C; Nardin M; Grisanti S; Rizzoni D; Berruti A; Paini A Front Cardiovasc Med; 2021; 8():651594. PubMed ID: 33778028 [No Abstract] [Full Text] [Related]
4. 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension. Wang TD; Lee YH; Chang SS; Tung YC; Yeh CF; Lin YH; Pan CT; Hsu CY; Huang CY; Wu CK; Sung PH; Chiang LT; Wang YC; Tsai WC; Lin TT; Lin CP; Chen WJ; Hwang JJ Acta Cardiol Sin; 2019 May; 35(3):199-230. PubMed ID: 31249454 [TBL] [Abstract][Full Text] [Related]
5. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Konings CJ; Kooman JP; Schonck M; Dammers R; Cheriex E; Palmans Meulemans AP; Hoeks AP; van Kreel B; Gladziwa U; van der Sande FM; Leunissen KM Perit Dial Int; 2002; 22(4):477-87. PubMed ID: 12322819 [TBL] [Abstract][Full Text] [Related]
6. Predictors of high central blood pressure in young with isolated systolic hypertension. Radchenko GD; Torbas OO; Sirenko YM Vasc Health Risk Manag; 2016; 12():321-8. PubMed ID: 27536127 [TBL] [Abstract][Full Text] [Related]
7. Vascular Endothelial Growth Factor Inhibitor Therapy and Cardiovascular and Renal Damage in Renal Cell Carcinoma. Lai S; Molfino A; Seminara P; Longo F; Innico G; Coppola B; Mastroluca D; Galani A; Dimko M; Aceto P; Lai C Curr Vasc Pharmacol; 2018 Jan; 16(2):190-196. PubMed ID: 28676023 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC; Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Hypertension: Which Goal for Which Patient? Jarraya F Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961 [TBL] [Abstract][Full Text] [Related]
10. Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects. Magen E; Viskoper JR; Mishal J; Priluk R; London D; Yosefy C J Hum Hypertens; 2005 Sep; 19(9):667-73. PubMed ID: 16034448 [TBL] [Abstract][Full Text] [Related]
11. Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study). Lopez-Sublet M; Girerd N; Bozec E; Machu JL; Ferreira JP; Zannad F; Mourad JJ; Rossignol P Am J Hypertens; 2019 Jun; 32(7):620-628. PubMed ID: 30753257 [TBL] [Abstract][Full Text] [Related]
12. Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis. Georgianos PI; Agarwal R Am J Kidney Dis; 2015 Aug; 66(2):305-12. PubMed ID: 25818679 [TBL] [Abstract][Full Text] [Related]
13. First Line CombinAtion Therapy in the Treatment of Stage II and III Hypertension (FLASH). Spirk D; Noll S; Burnier M; Rimoldi S; Noll G; Sudano I Front Cardiovasc Med; 2020; 7():46. PubMed ID: 32292790 [No Abstract] [Full Text] [Related]
14. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. Obara T; Ohkubo T; Funahashi J; Kikuya M; Asayama K; Metoki H; Oikawa T; Hashimoto J; Totsune K; Imai Y J Hypertens; 2005 Sep; 23(9):1653-60. PubMed ID: 16093909 [TBL] [Abstract][Full Text] [Related]
15. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. Thomopoulos C; Parati G; Zanchetti A J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension. Chen JM; Heran BS; Perez MI; Wright JM Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622 [TBL] [Abstract][Full Text] [Related]
17. Ambulatory blood pressure monitoring and peri-hemodialysis blood pressures in a southeast US hemodialysis unit. Fülöp T; Schmidt DW; Cosmin A; Islam N; Wells C; Lengvárszky Z; Bilbrew DM; Zsom L Clin Nephrol; 2012 May; 77(5):383-91. PubMed ID: 22551884 [TBL] [Abstract][Full Text] [Related]
18. [Association between long-term blood pressure change and the incidence of cardiovascular diseases: a population-based cohort study]. Han XY; Qi Y; Zhao D; Wang W; Wang M; Sun JY; Liu J; Li Y; Liu J Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Sep; 46(9):695-700. PubMed ID: 30293375 [No Abstract] [Full Text] [Related]
19. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency. Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of home and office blood pressure in hypertensive patients treated with enalapril/HCTZ 20/6 mg: the ESPADA study. Campo C; Fernández G; González-Esteban J; Segura J; Ruilope LM; Blood Press; 2000; 9(6):355-62. PubMed ID: 11212065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]